S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
Log in

NASDAQ:TMDI - Titan Medical Stock Price, Forecast & News

$0.39
-0.03 (-7.14 %)
(As of 02/18/2020 04:00 PM ET)
Today's Range
$0.39
Now: $0.39
$0.45
50-Day Range
$0.39
MA: $0.51
$0.64
52-Week Range
$0.38
Now: $0.39
$4.65
Volume268,400 shs
Average Volume379,031 shs
Market Capitalization$15.56 million
P/E RatioN/A
Dividend YieldN/A
Beta4.62
Titan Medical Inc, a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TMDI
CUSIPN/A
CIKN/A
Phone416-548-7522

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.19 per share

Profitability

Net Income$-22,640,000.00

Miscellaneous

Employees9
Market Cap$15.56 million
Next Earnings Date2/19/2020 (Estimated)
OptionableNot Optionable

Receive TMDI News and Ratings via Email

Sign-up to receive the latest news and ratings for TMDI and its competitors with MarketBeat's FREE daily newsletter.


Titan Medical (NASDAQ:TMDI) Frequently Asked Questions

What is Titan Medical's stock symbol?

Titan Medical trades on the NASDAQ under the ticker symbol "TMDI."

When is Titan Medical's next earnings date?

Titan Medical is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Titan Medical.

What price target have analysts set for TMDI?

3 equities research analysts have issued 12-month price targets for Titan Medical's stock. Their forecasts range from $1.50 to $1.50. On average, they anticipate Titan Medical's stock price to reach $1.50 in the next twelve months. This suggests a possible upside of 284.6% from the stock's current price. View Analyst Price Targets for Titan Medical.

What is the consensus analysts' recommendation for Titan Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Titan Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Titan Medical.

What are Wall Street analysts saying about Titan Medical stock?

Here are some recent quotes from research analysts about Titan Medical stock:
  • 1. According to Zacks Investment Research, "Titan Medical Inc. is focused on the design and development of a robotic surgical system for application in minimally invasive surgery. The Company's SPORT Surgical System includes a surgeon-controlled robotic platform which incorporates a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures through a single incision. The surgical system also includes a surgeon workstation which provides a surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments and viewing the inside of a patient's body in 3D during MIS procedures. Titan Medical Inc. is based in ON, Canada. " (1/21/2020)
  • 2. Northland Securities analysts commented, "We waited to have a call with management, and our summary underneath is a reflection of the information gleaned from our conversation." (7/18/2019)

Has Titan Medical been receiving favorable news coverage?

Media headlines about TMDI stock have been trending somewhat positive on Tuesday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Titan Medical earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Titan Medical.

Are investors shorting Titan Medical?

Titan Medical saw a drop in short interest in the month of January. As of January 31st, there was short interest totalling 342,200 shares, a drop of 44.6% from the January 15th total of 617,500 shares. Based on an average trading volume of 559,200 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.9% of the company's shares are short sold. View Titan Medical's Current Options Chain.

Who are some of Titan Medical's key competitors?

What other stocks do shareholders of Titan Medical own?

Who are Titan Medical's key executives?

Titan Medical's management team includes the folowing people:
  • Mr. David J. McNally, Pres, CEO & Director (Age 57)
  • Mr. Stephen D. Randall, CFO, Sec. & Director
  • Dr. Perry A. Genova, Sr. VP of R&D
  • Mr. Curtis R. Jensen, VP of Quality & Regulatory Affairs
  • Mr. Sachin A. Sankholkar, VP of Marketing

Who are Titan Medical's major shareholders?

Titan Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Masters Capital Management LLC (2.76%), Perritt Capital Management Inc. (0.50%), Renaissance Technologies LLC (0.22%) and Capital One National Association (0.16%).

Which major investors are selling Titan Medical stock?

TMDI stock was sold by a variety of institutional investors in the last quarter, including Masters Capital Management LLC and Perritt Capital Management Inc..

Which major investors are buying Titan Medical stock?

TMDI stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Capital One National Association.

How do I buy shares of Titan Medical?

Shares of TMDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Titan Medical's stock price today?

One share of TMDI stock can currently be purchased for approximately $0.39.

How big of a company is Titan Medical?

Titan Medical has a market capitalization of $15.56 million. The company earns $-22,640,000.00 in net income (profit) each year or ($1.36) on an earnings per share basis. Titan Medical employs 9 workers across the globe.View Additional Information About Titan Medical.

What is Titan Medical's official website?

The official website for Titan Medical is http://www.titanmedicalinc.com/.

How can I contact Titan Medical?

Titan Medical's mailing address is 170 UNIVERSITY AVENUE, TORONTO A6, M5H 3B3. The company can be reached via phone at 416-548-7522.


MarketBeat Community Rating for Titan Medical (NASDAQ TMDI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  252
MarketBeat's community ratings are surveys of what our community members think about Titan Medical and other stocks. Vote "Outperform" if you believe TMDI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TMDI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Profit Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel